股票代码：******

Safeguarding Drug Safety with the Weight of Mount Tai; Securing Quality as the Lifeline of Our Enterprise.

The Company fully implements the national requirements on drug supervision, resolutely enforces the “Four Strictest” principles, and strictly complies with the Drug Administration Law of the PRC and the Good Manufacturing Practice (GMP) standards. We fulfil our primary responsibility as a drug manufacturer to the highest standards, safeguarding public medication safety with the most rigorous measures.

Our Commitment to Safe Production

· Strict Compliance, Integrity First:

We strictly observe drug administration laws, regulations, and all quality standards, upholding the bottom line of drug safety. We never produce or sell counterfeit or substandard drugs, never manufacture beyond the approved scope, never change prescriptions or processes without authorization, and never fabricate or falsify production and testing records, ensuring all production processes are lawful and compliant.

· Comprehensive Systems, Full-Cycle Control:

We have established a sound quality management system covering the entire drug lifecycle, including R&D, production, testing, storage, and sales. All production activities are organized strictly in accordance with approved processes and operating procedures to ensure the continuous and stable supply of safe and effective medicines.

· Rigorous Source Control, Strong Defences:

We strictly implement supplier audits and access systems. All raw and auxiliary materials, as well as packaging materials, must pass inspection before storage and use. Batch-by-batch inspection is enforced, and non-conforming materials are strictly prohibited from entering production, building a solid safety barrier at the source.

· Standardized Production, Process Control:

All production operators must undergo training and assessment before assuming their roles, and strictly adhere to job responsibilities and operating procedures. Key parameters in clean areas, including temperature, humidity, pressure differentials, and cleanliness, are monitored in real time, with regular environmental monitoring and disinfection carried out to prevent cross-contamination and microbial risks.

· Rigorous Testing, Prudent Release:

We implement a “three-level inspection” system of self-inspection, mutual inspection, and special inspection, conducting multiple tests on intermediates, semi-finished products, and finished products. All finished products must be reviewed and approved by the quality director before release; products not meeting quality standards are strictly prohibited from circulation.

· Pharmacovigilance, Full Traceability:

We have established a comprehensive information-based traceability and pharmacovigilance system to ensure records are truthful, accurate, complete, and traceable. We promptly monitor and report adverse drug reactions, and proactively take risk-control measures such as recalls or sales suspension to safeguard public drug safety.

· Self-Discipline and Accountability, Open to Supervision:

We actively assume primary responsibility for drug safety, consciously accepting supervision from government, industry, media, and the public. We respond promptly to quality inquiries and complaints, actively promote drug safety knowledge, and jointly uphold the good image of pharmaceutical enterprises.

Our Values and Commitment

Safe production is not a slogan, but the responsibility and conviction of Jiangxi Biology. We uphold “Quality First, Patients Foremost” as our core philosophy, translating respect for and responsibility towards life into every step of our work. With the strictest standards, we ensure drug safety and efficacy, contributing to public health and the high-quality development of the industry.

Add:

Address: No. 198 Huoju Avenue, Jinggangshan Economic & Technological Development Zone, Ji’an, Jiangxi, China

Board Office:

Domestic Sales:

International Sales:

Complaint & Report Hotline:

+86-796-8403905